| ACEI | Angiotensin-converting enzyme inhibitor |
| ARB | Angiotensin receptor blocker |
| ARNI | Angiotensin receptor–neprilysin inhibitor |
| CI | Confidence interval |
| CKD | Chronic kidney disease |
| CKD-EPI | Chronic Kidney Disease Epidemiology Collaboration |
| COPD | Chronic obstructive pulmonary disease |
| eGFR | Estimated glomerular filtration rate |
| EHR | Electronic health record |
| GEE | Generalized estimating equations |
| GDMT | Guideline-directed medical therapy |
| HF | Heart failure |
| HFimpEF | Heart failure with improved ejection fraction |
| HFmrEF | Heart failure with mildly reduced ejection fraction |
| HFpEF | Heart failure with preserved ejection fraction |
| HFrEF | Heart failure with reduced ejection fraction |
| ICD-10 | International Classification of Diseases, Tenth Revision |
| IQR | Interquartile range |
| LVEF | Left ventricular ejection fraction |
| LVSD | Left ventricular systolic dysfunction |
| MRA | Mineralocorticoid receptor antagonist |
| NPV | Negative predictive value |
| OR | Odds ratio |
| PPV | Positive predictive value |
| RAAS | Renin-angiotensin-aldosterone system |
| RECORD | REporting of studies Conducted using Observational Routinely-collected health Data |
| SD | Standard deviation |
| SGLT2i | Sodium-glucose cotransporter-2 inhibitor |
| SMD | Standardized mean difference |
| T1DM | Type 1 diabetes mellitus |
| T2DM | Type 2 diabetes mellitus |
| HR | Hazard ratio |